This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (10)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

A Controlled Toxicity Study

EDWIN T. WRIGHT, MD; MARTIN WOLBORSKY, MD; EDGAR E. HAMER, MD

Arch Dermatol. 1966;93(6):731-736.

Abstract
Methotrexate was administered intramuscularly to ten patients with severe psoriasis and one patient with a generalized erythroderma. All patients were observed carefully for toxicity by the use of a number of laboratory procedures. Clinical improvement was compared with a control group receiving placebo injections and standard dermatologic topical therapy. The results indicate that methotrexate administered intramuscularly is a therapeutically beneficial drug; however, it is a potentially toxic drug, unless precautions are observed.

Author Affiliations
LOS ANGELES

From the Dermatology Section, Medical Service, Wadsworth Hospital, Veterans Administration Center, Los Angeles, and the Department of Medicine, Division of Dermatology, UCLA Center for the Health Sciences, Los Angeles.

Footnotes
Accepted for publication March 14, 1966.

Reprint requests to Veterans Administration, Wilshire and Sawtelle Blvd, Los Angeles 90073 (Dr. Wright).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Liver Disease Associated With Methotrexate Treatment of Psoriatic Patients
Dubin and Harrell
Arch Dermatol 1970;102:498-503.
ABSTRACT  

Cirrhosis Following Methotrexate Administration for Psoriasis
Epstein and Croft
Arch Dermatol 1969;100:531-534.
ABSTRACT